This white paper provides knowledge on Adventitious Virus Testing, covering regulatory authorities, Next Generation Sequencing, bioinformatics and computer system validation.
Regulatory Context
Authorities increasingly accept NGS as a broad-spectrum alternative to traditional assays.
NGS and Bioinformatics
Sequencing combined with validated analysis pipelines detects a wide range of potential contaminants.
Computer System Validation
GMP use requires validated software and documented data handling.
About This White Paper
This white paper is published by IDT Biologika and curated by Biotechnology Media Insights, a trusted source for pharmaceutical and biotechnology research, technical guides and industry analysis.